Search results
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 2 days agoThis week, an FDA advisory committee unanimously recommended approval of Eli Lilly’s LLY Alzheimer's...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 3 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily ...
Here's To Science! Pfizer, Moderna Look To Combo Flu/COVID Vaccines
MediaPost· 6 days agoAlbert Bourla, Pfizer’s chief executive officer, acknowledged on Monday that, because the company’s stock price was down at the time, he gave the final sign-off on running ...
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 3 days agoPharma giant Pfizer Inc. (NYSE: PFE) announced on Wednesday after markets closed that its gene...
Pfizer’s gene therapy for a muscle-wasting disorder misses main goal of late-stage study
WSAU Wausau· 4 days ago(Reuters) - Pfizer said on Wednesday its experimental gene therapy for a type of muscle-wasting...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer . Looking at options history for Pfizer PFE we ...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 5 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
Former Pfizer Worker’s 401(k) Account Won’t Be Given to Ex-Wife
Bloomberg Law· 2 days agoemployee can’t access his 401(k) account to satisfy a $75,000 judgment against him in a defamation lawsuit, a Pennsylvania federal judge said. Judge Juan R. Sánchez rejected her request with ...
Sun Pharma Prevails in Lipitor MDL on Class Certification, Summary Judgment | New Jersey Law Journal
Law.com· 5 days agoA group of Lipitor purchasers that included retailers, wholesalers, health insurance companies, and...
Sarepta shares rise as Pfizer DMD trial misses goals By Investing.com
Investing.com· 3 days agoOn Thursday, Piper Sandler maintained an Overweight rating on Sarepta Therapeutics (NASDAQ:SRPT)...